Chang Ming Shen1, Guang Cai Niu, Wei Cui, Hui Kai Li, Qiang Li. 1. Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Huan-Hu-Xi Road, He Xi District, Tianjin, 300060, China.
Abstract
OBJECTIVES: The aim of this study was to determine if there has been improvement in survival for patients with gallbladder cancer treated with surgical procedures. METHODS: A retrospective review of all patients with gallbladder cancer admitted during the past 11 years was conducted. The patients were categorized into two periods: period 1, from 1 January 2000 to 31 December 2005 (group 1, n = 77); and period 2, from 1 January 2006 to 31 December 2010 (group 2, n = 131). RESULTS: The two groups have similar age, sex distribution, and symptoms. There were more patients with advanced stage in group 2 (P = 0.001). And patients in group 2 were treated with more aggressive surgical procedures compared with group 1. Patients of group 2 had a better surgical outcomes and longer 5-year overall survival (9 % vs. 19 %, P = 0.040) and disease-free survival (P = 0.017). Median survival in group 1 was 14.7 months, while in group 2 it was 22.3 months. Patients underwent R0 resection in group 2 had better survival than that in group 1 (P = 0.009), while they had similar survival for those who underwent non-R0 resection in both periods (P = 0.108). CONCLUSIONS: A significant improvement of disease-free survival and long-term survival results was observed in the past decade.
OBJECTIVES: The aim of this study was to determine if there has been improvement in survival for patients with gallbladder cancer treated with surgical procedures. METHODS: A retrospective review of all patients with gallbladder cancer admitted during the past 11 years was conducted. The patients were categorized into two periods: period 1, from 1 January 2000 to 31 December 2005 (group 1, n = 77); and period 2, from 1 January 2006 to 31 December 2010 (group 2, n = 131). RESULTS: The two groups have similar age, sex distribution, and symptoms. There were more patients with advanced stage in group 2 (P = 0.001). And patients in group 2 were treated with more aggressive surgical procedures compared with group 1. Patients of group 2 had a better surgical outcomes and longer 5-year overall survival (9 % vs. 19 %, P = 0.040) and disease-free survival (P = 0.017). Median survival in group 1 was 14.7 months, while in group 2 it was 22.3 months. Patients underwent R0 resection in group 2 had better survival than that in group 1 (P = 0.009), while they had similar survival for those who underwent non-R0 resection in both periods (P = 0.108). CONCLUSIONS: A significant improvement of disease-free survival and long-term survival results was observed in the past decade.
Authors: Jason M Foster; Hisakazu Hoshi; John F Gibbs; Renuka Iyer; Miland Javle; Quyen Chu; Boris Kuvshinoff Journal: Ann Surg Oncol Date: 2006-11-11 Impact factor: 5.344
Authors: Michael D'Angelica; Kimberly Moore Dalal; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin Journal: Ann Surg Oncol Date: 2008-11-05 Impact factor: 5.344
Authors: Anu Behari; Sadiq S Sikora; Gajanan D Wagholikar; Ashok Kumar; Rajan Saxena; Vinay K Kapoor Journal: J Am Coll Surg Date: 2003-01 Impact factor: 6.113
Authors: John R Doty; John L Cameron; Charles J Yeo; Kurtis Campbell; JoAnn Coleman; Ralph H Hruban Journal: J Gastrointest Surg Date: 2002 Sep-Oct Impact factor: 3.452